Target intelligence / Profile preview

Radixin pseudogene 1 (RDXP1)

Target: RDXP1
Molecular classification: Pseudogene

Overview

Radixin pseudogene 1 (RDXP1) is a human pseudogene mapped to chromosome 11p, representing a non-functional genomic sequence related to the radixin (RDX) gene. Unlike the protein-coding RDX, which plays critical roles in cytoskeleton-membrane interactions and disease, RDXP1 does not produce a functional protein and is not considered a therapeutic target[1][3][5]. There is currently no evidence for biological function, disease relevance, or drug interaction for RDXP1. Its classification is strictly as a pseudogene.

Other names: radixin pseudogene 1RDXP1

Beyond the preview

Go deeper on Radixin pseudogene 1 (RDXP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radixin pseudogene 1 (RDXP1).

Explore the full profile